Assignee
PELICAN THERAPEUTICS INC
US·4 granted patents·4 pending applications·6 citations·filing 2015–2020
Top patents by PatentIndex Score
8 records- 0189US10683359B2Anti-TNFRSF25 antibodiesPELICAN THERAPEUTICS INC·Filed 2018·Granted Jun 16, 2020·3 cites·10 claims
- 0279US10005843B2Anti-TNFRSF25 antibodiesPELICAN THERAPEUTICS INC·Filed 2017·Granted Jun 26, 2018·2 cites·18 claims
- 0374US9982057B2Human TNFRSF25 antibodyPELICAN THERAPEUTICS INC·Filed 2015·Granted May 29, 2018·1 cites·10 claims
- 0465US10683358B2Human TNFRSF25 antibodyPELICAN THERAPEUTICS INC·Filed 2018·Granted Jun 16, 2020·0 cites·10 claims
- 0564US2020392238A1Human tnfrsf25 antibodyPELICAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0663US2021017287A1Anti-tnfrsf25 antibodiesPELICAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0751US2022298252A1Methods of treating cancer using tnfrsf25 antibodiesPELICAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0846US2022340672A1Tnfrsf25-mediated treatments of immune diseases and disordersPELICAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →